Market Overview

UPDATE: ISI Group Initiates CVS Caremark at Overweight, $53.50 PT

Related CVS
Will Rite Aid (RAD) Miss Estimates this Earnings Season?
Benzinga's Top Upgrades
Home Depot Investigates Potential Hacking, CVS Says Farewell to Tobacco Products (Fox Business)
Related CVS
Will Rite Aid (RAD) Miss Estimates this Earnings Season?
Benzinga's Top Upgrades
Home Depot Investigates Potential Hacking, CVS Says Farewell to Tobacco Products (Fox Business)

ISI Group initiated its coverage on CVS Caremark (NYSE: CVS) with a rating of Overweight and a price target of $53.50.

ISI Group commented, "Our thesis for CVS is based on our view of continued share gain at the pharmacy given the success of Maintenance Choice and the continuation of the WAG/ESRX dispute, improved growth and profitability at Caremark as a result of innovative solutions and the streamlining initiative, and a very shareholder friendly approach to capital deployment and enhanced capital returns."

CVS Caremark closed at $46.90 on Wednesday.

Latest Ratings for CVS

DateFirmActionFromTo
Sep 2014Cowen & CompanyUpgradesMarket PerformOutperform
Aug 2014BarclaysMaintainsOverweight
Aug 2014JP MorganMaintainsOverweight

View More Analyst Ratings for CVS
View the Latest Analyst Ratings

Posted-In: ISI GroupAnalyst Color Initiation Intraday Update Analyst Ratings

 

Related Articles (CVS)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters